Bruce Warner
Recent stories
Implications for safer practice of CD incidents reported to the NRLSSubscription
Seven years’ worth of Controlled Drugs incident reports have been reviewed by the National Reporting and Learning System and the results used to inform safer practice
Passport to the safer use of insulinSubscription
Of the 16,600 insulin related reports received by the National Reporting and Learning System between 2003 and 2009, 26 per cent registered wrong dose, strength or frequency and 14 per cent described patients being prescribed or receiving (or both) the wrong product. The look-alike and sound-alike names of insulin products (eg, Novorapid and Novomix) and subtle differences (eg, Humulin S, I and M3) is a
Recent blog posts
Introducing the Stay Well Pharmacy campaign
Bruce Warner, deputy chief pharmaceutical officer for England, presents the Stay Well Pharmacy campaign, a new national initiative launched by NHS England.
